China Jo - Jo Drugstores (CJJD)
China Jo - Jo Drugstores R&D Expense: 0.00
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
CJJD R&D Expense Rankings
| Overall | 99th percentile | 13 of 1764 |
| Sector | 98th percentile | 3 of 197 in Services |
| Industry | 50th percentile | 1 of 2 in Drug Stores |
CJJD R&D Expense Range, Past 5 Years
| Minimum | 0.00 | Jun 2010 |
| Maximum | 0.00 | Jun 2010 |
| Average | 0.00 |
About R&D Expense
R&D expenses are a line item from many companies' income statements.
R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.
Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.
An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More
You may also be interested in these CJJD related companies
CJJD News
China Jo-Jo Drugstores Announces New Store Openings in Shanghai and Hangzhou
May 17, 6:39AM Benzinga
May 17, 6:39AM Benzinga
$CJJD forms bullish "Bottom Triangle" chart pattern. http://stks.co/2x6P
about 70 days ago by RecogniaEvents
about 70 days ago by RecogniaEvents
$CJJD forms bearish "Symmetrical Continuation Triangle" chart pattern. http://stks.co/2epC
about 87 days ago by RecogniaEvents
about 87 days ago by RecogniaEvents
China Jo-Jo Drugstores Inc. Reports Financial Results for Third Quarter 2012
Feb 14, 6:00AM Business Wire
Feb 14, 6:00AM Business Wire
China Jo-Jo Drugstore expects to open approximately 15-20 new locations in FY12
Aug 15, 6:18AM FlyOnTheWall
Aug 15, 6:18AM FlyOnTheWall
China Jo-Jo Drugstores, Inc. Reports Record First Quarter 2012 Financial Results
Aug 15, 6:00AM Business Wire
Aug 15, 6:00AM Business Wire
China Jo-Jo Drugstores, Inc. Reports Fiscal 2011 Fourth Quarter and Full Year Financial Results
Jun 29, 5:28PM Business Wire
Jun 29, 5:28PM Business Wire
China Jo-Jo Drugstores Announces Fourth Quarter and Full Year Fiscal 2011 Conference Call
Jun 28, 4:40PM Business Wire
Jun 28, 4:40PM Business Wire
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CJJD | 0.97 | +0.00 | +0.41% | 13.12M |
| CJES | 18.58 | +0.23 | +1.25% | 964.12M |
| CIX | 13.07 | +0.07 | +0.54% | 161.94M |
| CITZ | 5.38 | +0.06 | +1.13% | 58.75M |
| CIT | 34.79 | -0.37 | -1.05% | 6.986B |
| CISG | 7.00 | -0.07 | -0.99% | 353.85M |
| CIS | 1.99 | -0.14 | -6.57% | 88.36M |
| CINF | 35.66 | +0.02 | +0.06% | 5.789B |
| CIMT | 4.314 | +0.00 | +0.04% | 42.76M |
| CIM | 2.82 | +0.03 | +1.08% | 2.897B |
